These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 2990275)

  • 1. The acquired immunodeficiency syndrome in a cohort of homosexual men. A six-year follow-up study.
    Jaffe HW; Darrow WW; Echenberg DF; O'Malley PM; Getchell JP; Kalyanaraman VS; Byers RH; Drennan DP; Braff EH; Curran JW
    Ann Intern Med; 1985 Aug; 103(2):210-4. PubMed ID: 2990275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Seroepidemiology of human T-lymphotropic virus type III among homosexual men with the acquired immunodeficiency syndrome or generalized lymphadenopathy and among asymptomatic controls in Boston.
    Groopman JE; Mayer KH; Sarngadharan MG; Ayotte D; Devico AL; Finberg R; Sliski AH; Allan JD; Gallo RC
    Ann Intern Med; 1985 Mar; 102(3):334-7. PubMed ID: 2982305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Persistent infection with human T-lymphotropic virus type III/lymphadenopathy-associated virus in apparently healthy homosexual men.
    Jaffe HW; Feorino PM; Darrow WW; O'Malley PM; Getchell JP; Warfield DT; Jones BM; Echenberg DF; Francis DP; Curran JW
    Ann Intern Med; 1985 May; 102(5):627-8. PubMed ID: 2984973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determinants of retrovirus (HTLV-III) antibody and immunodeficiency conditions in homosexual men.
    Goedert JJ; Sarngadharan MG; Biggar RJ; Weiss SH; Winn DM; Grossman RJ; Greene MH; Bodner AJ; Mann DL; Strong DM
    Lancet; 1984 Sep; 2(8405):711-6. PubMed ID: 6148471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective study of cytotoxic T lymphocyte responses to influenza and antibodies to human T lymphotropic virus-III in homosexual men. Selective loss of an influenza-specific, human leukocyte antigen-restricted cytotoxic T lymphocyte response in human T lymphotropic virus-III positive individuals with symptoms of acquired immunodeficiency syndrome and in a patient with acquired immunodeficiency syndrome.
    Shearer GM; Salahuddin SZ; Markham PD; Joseph LJ; Payne SM; Kriebel P; Bernstein DC; Biddison WE; Sarngadharan MG; Gallo RC
    J Clin Invest; 1985 Oct; 76(4):1699-704. PubMed ID: 2997287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unexplained lymphadenopathy in homosexual men. A longitudinal study.
    Fishbein DB; Kaplan JE; Spira TJ; Miller B; Schonberger LB; Pinsky PF; Getchell JP; Kalyanaraman VS; Braude JS
    JAMA; 1985 Aug; 254(7):930-5. PubMed ID: 2991618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Introduction of lymphadenopathy associated virus or human T lymphotropic virus (LAV/HTLV-III) into the male homosexual community in Amsterdam.
    Coutinho RA; Krone WJ; Smit L; Albrecht-van Lent P; van der Noordaa J; Schaesberg W; Goudsmit J
    Genitourin Med; 1986 Feb; 62(1):38-43. PubMed ID: 3005159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of IgG antibodies to lymphadenopathy-associated virus in patients with AIDS or lymphadenopathy syndrome.
    Brun-Vezinet F; Rouzioux C; Barre-Sinoussi F; Klatzmann D; Saimot AG; Rozenbaum W; Christol D; Gluckmann JC; Montagnier L; Chermann JC
    Lancet; 1984 Jun; 1(8389):1253-6. PubMed ID: 6144973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Seroepidemiological studies of human T-lymphotropic retrovirus type III in acquired immunodeficiency syndrome.
    Safai B; Sarngadharan MG; Groopman JE; Arnett K; Popovic M; Sliski A; Schüpbach J; Gallo RC
    Lancet; 1984 Jun; 1(8392):1438-40. PubMed ID: 6145881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relation of HTLV-III seropositivity and lymphadenopathy.
    Jeffries E; Boyko WJ; Willoughby B; Constance PD; Wiggs B; O'Shaughnessy M; Sharp FR
    Can Med Assoc J; 1985 Jul; 133(2):111-2. PubMed ID: 2988732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IgG-antibodies to HTLV-III in patients with AIDS, LAS, and persons at risk of AIDS in West Germany.
    Hehlmann R; Kreeb G; Erfle V; Piechowiak H; Krüger G; Goebel FD
    Blut; 1985 Jan; 50(1):13-8. PubMed ID: 2981593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical findings and serological evidence of HTLV-III infection in homosexual contacts of patients with AIDS and persistent generalised lymphadenopathy in London.
    Gazzard BG; Shanson DC; Farthing C; Lawrence AG; Tedder RS; Cheingsong-Popov R; Dalgleish A; Weiss RA
    Lancet; 1984 Sep; 2(8401):480-3. PubMed ID: 6147547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exposure to human T-lymphotropic virus type III/lymphadenopathy-associated virus and immunologic abnormalities in asymptomatic homosexual men.
    Nicholson JK; McDougal JS; Jaffe HW; Spira TJ; Kennedy MS; Jones BM; Darrow WW; Morgan M; Hubbard M
    Ann Intern Med; 1985 Jul; 103(1):37-42. PubMed ID: 2988389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between antibody to LAV/HTLV-III and the natural course of subclinical cellular immune dysfunction in homosexual men.
    Collier AC; Meyers JD; Murphy VL; Roberts PL; Getchell JP; Handsfield HH
    Sex Transm Dis; 1987; 14(1):1-8. PubMed ID: 3645805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The AIDS epidemic.
    Landesman SH; Ginzburg HM; Weiss SH
    N Engl J Med; 1985 Feb; 312(8):521-5. PubMed ID: 2982097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of antibody to human T-lymphotropic virus type III in AIDS and AIDS-risk patients in Britain.
    Cheingsong-Popov R; Weiss RA; Dalgleish A; Tedder RS; Shanson DC; Jeffries DJ; Ferns RB; Briggs EM; Weller IV; Mitton S
    Lancet; 1984 Sep; 2(8401):477-80. PubMed ID: 6147546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiology of human T-lymphotropic virus type III and the risk of the acquired immunodeficiency syndrome.
    Blattner WA; Biggar RJ; Weiss SH; Melbye M; Goedert JJ
    Ann Intern Med; 1985 Nov; 103(5):665-70. PubMed ID: 2996397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of HTLV-III/LAV in household contacts of patients with confirmed AIDS and controls in Kinshasa, Zaire.
    Mann JM; Quinn TC; Francis H; Nzilambi N; Bosenge N; Bila K; McCormick JB; Ruti K; Asila PK; Curran JW
    JAMA; 1986 Aug; 256(6):721-4. PubMed ID: 3014178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relationship of abnormalities of cellular immunity to antibodies to HTLV-III in homosexual men.
    Dobozin BS; Judson FN; Cohn DL; Penley KA; Rickmann PE; Blaser MJ; Sarin PS; Weiss SH; Kirkpatrick CH
    Cell Immunol; 1986 Mar; 98(1):156-71. PubMed ID: 3017581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Additional recommendations to reduce sexual and drug abuse-related transmission of human T-lymphotropic virus type III/lymphadenopathy-associated virus.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1986 Mar; 35(10):152-5. PubMed ID: 3005822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.